These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2286705)

  • 1. Effect of posture on imipramine and desipramine plasma concentrations.
    Abalan F; Schweiger K; Hecquet D; Brachet-Liermain A; Sousselier M; Rigal F
    J Clin Psychopharmacol; 1990 Aug; 10(4):301-2. PubMed ID: 2286705
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of depression to very high plasma levels of imipramine plus desipramine.
    Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB
    Biol Psychiatry; 1991 Jul; 30(1):57-62. PubMed ID: 1892963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
    Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
    J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of imipramine and metabolites in 68 hospitalized children.
    Preskorn SH; Bupp SJ; Weller EB; Weller RA
    J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):373-5. PubMed ID: 2738003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
    Bergstrom RF; Peyton AL; Lemberger L
    Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of imipramine and desipramine.
    Sallee FR; Pollock BG
    Clin Pharmacokinet; 1990 May; 18(5):346-64. PubMed ID: 2185906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers.
    Ciraulo DA; Barnhill JG; Jaffe JH
    Clin Pharmacol Ther; 1988 May; 43(5):509-18. PubMed ID: 3365915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
    Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear kinetics of imipramine in low and medium plasma level ranges.
    Sindrup SH; Brøsen K; Gram LF
    Ther Drug Monit; 1990 Sep; 12(5):445-9. PubMed ID: 2293406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distribution of imipramine, desipramine and specific [3H]desipramine binding sites in the rat brain after acute and chronic treatment with imipramine.
    Daniel W; Danek L; Janczar L; Nocon H; Melzacka M
    J Pharm Pharmacol; 1991 Jan; 43(1):31-5. PubMed ID: 1676056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-imipramine binding in the frontal cortex of suicides.
    Arora RC; Meltzer HY
    Psychiatry Res; 1989 Nov; 30(2):125-35. PubMed ID: 2559421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine.
    Daniel W; Melzacka M
    J Pharm Pharmacol; 1992 May; 44(5):429-32. PubMed ID: 1359059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine: a model substance in pharmacokinetic research.
    Gram LF
    Acta Psychiatr Scand Suppl; 1988; 345():81-4. PubMed ID: 3067542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.